When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 10 Hits
  • Search Condition : Filter (MeSH = Niacinamide / analogs & derivatives*)
Species Resource
Medaka fli1::GFP (TG1206) , Kyoto-Cab Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
Human and Animal Cells HuCCT1(RCB1960) Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
Human and Animal Cells Hep G2(RCB1886) , PK-1(RCB1972) , KLM-1(RCB2138) Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
Human and Animal Cells RBE(RCB1292) , YSCCC(RCB1549) Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Human and Animal Cells Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Human and Animal Cells Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Human and Animal Cells Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
Human and Animal Cells A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Human and Animal Cells Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Human and Animal Cells HL60 Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.